BIS(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-NONACOSAFLUOROHEXADECYL) PHOSPHATE
UNII 3WJ5NUG8C4

Substance Identification & Data

This profile provides standardized clinical and technical data for Bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadecyl) Phosphate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3WJ5NUG8C4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 93857-53-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3WJ5NUG8C4

CAS Registry Number

93857-53-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BIS(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-NONACOSAFLUOROHEXADECYL) PHOSPHATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C32H9F58O4P

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VAPDLYGIEFOUOV-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

3022289

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(COP(=O)(O)OCCC(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadecyl) Phosphate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.